Morgan Stanley Capital International (MSCI)-designed Bangladesh Investable Market Index (IMI) showed an upward trend in the last month.
The monthly review of the index showed that dividend yield of the MSCI Bangladesh IMI stood at 3 per cent at the end of August, 2017 while price earnings ratio reached 14.26 points.
The report also mentioned that annual gross return stood at 27.92 per cent at the end of August while the same return for MSCI Frontier Market IMI stood at 21.90 per cent.
The MSCI Bangladesh IMI is designed to measure the performance of the large, mid and small cap segments of the equity market of the country. With 45 constituents, the index covers approximately 99 per cent of the free float-adjusted market capitalisation in Bangladesh.
The top-10 constituents of the index are: Square Pharmaceuticals, Brac Bank, Grameenphone, Olympic Industries, Beximco Pharma, Lafarge Surma Cement, The City Bank, National Bank, BEXIMCO and Summit Power.
These 10 listed companies occupied around 53 per cent weight of the index.
